Pathway in cancer, mTOR signaling pathway, MAPK signaling pathway, VEGF signaling pathway, and JAK-STAT signaling pathway were significantly enriched in the high-risk group (P < 0.05, FDR<0.25). This evidence concerns the gene MTOR and cancer.